Northwest & Ethical Investments L.P. Sells 1,228 Shares of Unilever PLC (NYSE:UL)

Northwest & Ethical Investments L.P. trimmed its stake in shares of Unilever PLC (NYSE:UL) by 5.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,951 shares of the company’s stock after selling 1,228 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Unilever were worth $1,491,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Fiera Capital Corp boosted its position in shares of Unilever by 1,866.0% during the 2nd quarter. Fiera Capital Corp now owns 2,135,859 shares of the company’s stock valued at $117,451,000 after acquiring an additional 2,027,221 shares during the last quarter. Jennison Associates LLC raised its stake in Unilever by 981.6% during the third quarter. Jennison Associates LLC now owns 2,076,169 shares of the company’s stock valued at $134,868,000 after purchasing an additional 1,884,216 shares in the last quarter. Bank of Montreal Can lifted its position in Unilever by 249.5% during the second quarter. Bank of Montreal Can now owns 1,748,329 shares of the company’s stock valued at $98,204,000 after purchasing an additional 1,248,136 shares during the last quarter. Clearbridge Investments LLC grew its stake in shares of Unilever by 598.7% in the 2nd quarter. Clearbridge Investments LLC now owns 1,301,239 shares of the company’s stock worth $71,555,000 after buying an additional 1,114,992 shares in the last quarter. Finally, Fisher Asset Management LLC increased its holdings in shares of Unilever by 7.1% in the 3rd quarter. Fisher Asset Management LLC now owns 16,726,400 shares of the company’s stock worth $1,086,547,000 after buying an additional 1,114,177 shares during the last quarter. 9.67% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on UL. StockNews.com downgraded shares of Unilever from a “buy” rating to a “hold” rating in a report on Tuesday, November 12th. Erste Group Bank reiterated a “hold” rating on shares of Unilever in a report on Tuesday, November 19th. Finally, Bank of America raised Unilever from an “underperform” rating to a “buy” rating and boosted their target price for the company from $47.00 to $72.00 in a research report on Thursday, August 22nd. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $61.75.

Unilever Price Performance

Shares of NYSE:UL opened at $59.84 on Friday. Unilever PLC has a 1 year low of $46.46 and a 1 year high of $65.87. The firm has a market capitalization of $148.43 billion, a PE ratio of 17.97, a price-to-earnings-growth ratio of 1.81 and a beta of 0.49. The business has a 50 day simple moving average of $61.34 and a two-hundred day simple moving average of $59.77.

Unilever Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 8th will be given a $0.4755 dividend. This represents a $1.90 annualized dividend and a yield of 3.18%. The ex-dividend date is Friday, November 8th. This is an increase from Unilever’s previous quarterly dividend of $0.35. Unilever’s dividend payout ratio is 56.46%.

Unilever Company Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.